Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759
Clinical trial NCT03360929 · COMPLETED
Trial details
- NCT number
- NCT03360929
- Sponsor
- LYZZ Alpha Holding Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2020-11-13
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.